GLMD Latest Headlines

Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice

at www.tipranks.com (Fri, 30-Jan 4:58 PM)

Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice

at seekingalpha.com (Fri, 30-Jan 4:29 PM)

Galmed Pharmaceuticals Unveils Potent Anti-Tumor Drug Synergy, Eyes Early-2026 Phase 1b Trial

Market Chameleon (Tue, 18-Nov 10:32 AM)

Galmed’s 3-Drug Combination Shows Enhanced Tumor Cell Killing: What the New Study Means for GI Cancer and the Future of Stivarga

Market Chameleon (Mon, 17-Nov 9:53 AM)